Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(100.0%)

2Total

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07355829Not ApplicableCompleted

DemTool - Supporting Life With Dementia

Role: lead

NCT05175664Completed

Novel Diagnostic and Disease Stage Biomarkers in AD

Role: lead

NCT04436341Completed

Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia

Role: lead

NCT05740683Recruiting

Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

Role: lead

NCT06621758Not Yet Recruiting

Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD

Role: lead

NCT06567431Recruiting

Blood And Tears in Alzheimer's Disease

Role: lead

NCT05768425Active Not Recruiting

DIagnostic Biomarkers and Symptoms in Patients With Alzheimer's Disease and Lewy bodY Dementia

Role: lead

NCT04593290Not ApplicableCompleted

Listen Carefully: An Exploratory Study of the Association Between Listening Effort and Cognitive Function

Role: collaborator

NCT04304859Completed

Brief Assessment of Impaired Cognition

Role: lead

All 9 trials loaded